BARD1 and Ewing sarcoma: It is unknown whether the presence of a germline pathogenic variant in a DNA damage repair gene such as BARD1 is able to further disrupt DNA damage repair and enhance sensitivity of Ewing tumor cells to DNA-damaging agents.